Quality by Design for enabling RNA platform production processes. (2022)
Attributed to:
Meeting the UK demand for COVID19/SARS-CoV-2 vaccines via integrated manufacturing and supply chain optimisation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.tibtech.2022.03.012
PubMed Identifier: 35491266
Publication URI: http://europepmc.org/abstract/MED/35491266
Type: Journal Article/Review
Volume: 40
Parent Publication: Trends in biotechnology
Issue: 10
ISSN: 0167-7799